165 related articles for article (PubMed ID: 33031305)
21. Immunologic effects of allogeneic versus autologous blood transfusion in patients undergoing radical oesophagectomy.
Takemura M; Osugi H; Takada N; Kinoshita H; Higashino M
Eur Surg Res; 2003; 35(2):115-22. PubMed ID: 12679622
[TBL] [Abstract][Full Text] [Related]
22. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.
Wada H; Eguchi H; Nagano H; Kubo S; Nakai T; Kaibori M; Hayashi M; Takemura S; Tanaka S; Nakata Y; Matsui K; Ishizaki M; Hirokawa F; Komeda K; Uchiyama K; Kon M; Doki Y; Mori M
Surg Today; 2018 Jan; 48(1):73-79. PubMed ID: 28597349
[TBL] [Abstract][Full Text] [Related]
23. Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery.
Heiss MM; Fasol-Merten K; Allgayer H; Ströhlein MA; Tarabichi A; Wallner S; Eissner HI; Jauch KW; Schildberg FW
Vox Sang; 1997; 73(4):237-45. PubMed ID: 9407641
[TBL] [Abstract][Full Text] [Related]
24. The effects of allogeneic and autologous blood transfusion on immune function in patients receiving total hip replacement.
Han ZZ; Li M; Zhang Y
Am J Transl Res; 2023; 15(7):4709-4717. PubMed ID: 37560247
[TBL] [Abstract][Full Text] [Related]
25. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous versus allogeneic blood transfusion in colorectal cancer surgery.
Heiss MM; Mempel W; Delanoff C; Jauch KW; Gabka C; Mempel M; Dieterich HJ; Eissner HJ; Schildberg FW
J Clin Oncol; 1994 Sep; 12(9):1859-67. PubMed ID: 8083709
[TBL] [Abstract][Full Text] [Related]
26. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
[TBL] [Abstract][Full Text] [Related]
27. [Arginine supplementation in total parenteral nutrition improves postoperative cellular immune function of patients with hepatocellular carcinoma after operation].
Zhou ZX; Zhang LJ; Huang XH; Kong QY; Zhou J
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Jul; 27(7):1094-6. PubMed ID: 17666360
[TBL] [Abstract][Full Text] [Related]
28. Natural Killer Cell Expansion with Autologous Feeder Layer and Anti-CD3 Antibody for Immune Cell Therapy of Hepatocellular Carcinoma.
Hosseinzadeh F; Ai J; Ebrahimi-Barough S; Seyhoun I; Hajifathali A; Muhammadnejad S; Hosseinzadeh F; Shadnoush M; Dabiri Oskouei F; Verdi J
Asian Pac J Cancer Prev; 2019 Dec; 20(12):3797-3803. PubMed ID: 31870124
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and peripheral immunity analysis of allogeneic natural killer cells therapy in patients with hepatocellular carcinoma].
Xie YB; Zhang JY; DU ML; Meng FP; Fu JL; Liu LM; Wang SS; Qu R; Lian F; Qiao F; Chen YL; Gao YY; Xu RN; Shi M; Wang FS
Beijing Da Xue Xue Bao Yi Xue Ban; 2019 Jun; 51(3):591-595. PubMed ID: 31209436
[TBL] [Abstract][Full Text] [Related]
30. Safety of the Use of Blood Salvage and Autotransfusion During Liver Transplantation for Hepatocellular Carcinoma.
Han S; Kim G; Ko JS; Sinn DH; Yang JD; Joh JW; Lee SK; Gwak MS
Ann Surg; 2016 Aug; 264(2):339-43. PubMed ID: 26501715
[TBL] [Abstract][Full Text] [Related]
31. Dysregulation of blood lymphocyte subsets and natural killer cells in schistosomal liver cirrhosis and hepatocellular carcinoma.
Attallah AM; Tabll AA; El-Sadany M; Ibrahim TA; El-Dosoky I
Clin Exp Med; 2003 Nov; 3(3):181-5. PubMed ID: 14648234
[TBL] [Abstract][Full Text] [Related]
32. Changes in immunological function after treatment with transarterial chemoembolization plus radiofrequency ablation in hepatocellular carcinoma patients.
Guan HT; Wang J; Yang M; Song L; Tong XQ; Zou YH
Chin Med J (Engl); 2013; 126(19):3651-5. PubMed ID: 24112158
[TBL] [Abstract][Full Text] [Related]
33. Effect of dosage of anticancer agents during transcatheter arterial chemoembolization on T cell subsets in patients with hepatocellular carcinoma.
Lu W; Li YH; He XF; Chen Y; Zeng QL; Qiu YR
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):524-6. PubMed ID: 12297475
[TBL] [Abstract][Full Text] [Related]
34. [Immune reconstitution after allogeneic peripheral blood stem cell transplantation].
Hong M; Li JY; Qian SX; Wu HX; Lu H; Zhang R; Zhang XY; Xu W
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1130-4. PubMed ID: 18928611
[TBL] [Abstract][Full Text] [Related]
35. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
[TBL] [Abstract][Full Text] [Related]
36. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.
Hanazaki K; Kajikawa S; Shimozawa N; Matsushita A; Machida T; Shimada K; Yazawa K; Koide N; Adachi W; Amano J
Hepatogastroenterology; 2005; 52(62):524-9. PubMed ID: 15816471
[TBL] [Abstract][Full Text] [Related]
37. Autologous versus allogeneic transfusions: no difference in perioperative outcome after partial hepatectomy. Autologous transfusion on hepatectomy outcome.
Park JO; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Wuest D; Blumgart LH; Jarnagin WR
J Gastrointest Surg; 2007 Oct; 11(10):1286-93. PubMed ID: 17665272
[TBL] [Abstract][Full Text] [Related]
38. Quantitative effect of natural killer-cell licensing on hepatocellular carcinoma recurrence after curative hepatectomy.
Tanimine N; Tanaka Y; Kobayashi T; Tashiro H; Miki D; Imamura M; Aikata H; Tanaka J; Chayama K; Ohdan H
Cancer Immunol Res; 2014 Dec; 2(12):1142-7. PubMed ID: 25135909
[TBL] [Abstract][Full Text] [Related]
39. Blood transfusion with autologous and leukocyte-depleted or standard allogeneic red blood cells and the immune response to open heart surgery.
Perttilä JT; Salo MS; Jalonen JR; Kuttila KT; Viinamäki O; Pulkki KJ
Anesth Analg; 1994 Oct; 79(4):654-60. PubMed ID: 7943771
[TBL] [Abstract][Full Text] [Related]
40. [Immunological influence of iodine-125 implantation in patients with hepatocellular carcinoma resection].
Xiang GA; Chen KY; Wang HN; Xiao JF
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Feb; 30(2):292-4. PubMed ID: 20159703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
